GRDN Stock Overview

A pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. More details

GRDN fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	3/6
Past Performance	0/6
Financial Health	6/6
Dividends	0/6

Rewards

Earnings are forecast to grow 115.16% per year

Risk Analysis

No risks detected for GRDN from our risk checks.

Guardian Pharmacy Services, Inc. Competitors

Walgreens Boots Alliance

NasdaqGS:WBA

US$9.4b

111

NasdaqGM:YI

US$65.1m

Grocery Outlet Holding

NasdaqGS:GO

US$1.4b

United Natural Foods

NYSE:UNFI

US$1.5b

Price History & Performance

Summary of share price highs, lows and changes for Guardian Pharmacy Services
Historical stock prices
Current Share Price	US$23.52
52 Week High	US$25.74
52 Week Low	US$14.16
Beta	0
1 Month Change	14.45%
3 Month Change	15.35%
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	47.00%

Recent updates

Guardian Pharmacy Services: Questions After A Successful IPO

Oct 02

Shareholder Returns

	GRDN	US Consumer Retailing	US Market
7D	9.4%	1.0%	-3.0%
1Y	n/a	30.8%	4.6%

Return vs Industry: Insufficient data to determine how GRDN performed against the US Consumer Retailing industry.

Return vs Market: Insufficient data to determine how GRDN performed against the US Market.

Price Volatility

Is GRDN's price volatile compared to industry and market?
GRDN volatility
GRDN Average Weekly Movement	7.0%
Consumer Retailing Industry Average Movement	6.2%
Market Average Movement	7.7%
10% most volatile stocks in US Market	16.9%
10% least volatile stocks in US Market	4.0%

Stable Share Price: GRDN has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: GRDN's weekly volatility (7%) has been stable over the past year.

Community vs My Fair Value

Select a narrative for quick price alerts from the community, or create your own.

About the Company

Founded	Employees	CEO	Website
2003	3,400	Fred Burke	guardianpharmacy.com

Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; GuardianShield Programs for LTCFs; Order Entry QA Analyzer, which utilizes real-time rules- engine technology to examine prescriptions and detect omissions and/or errors before they become a customer service problem; and Medication Spend Analyzer to break down the monthly drug spending for each of the LTCFs.

Guardian Pharmacy Services, Inc. Fundamentals Summary

How do Guardian Pharmacy Services's earnings and revenue compare to its market cap?
GRDN fundamental statistics
Market cap	US$1.48b
Earnings (TTM)	-US$110.05m
Revenue (TTM)	US$1.23b

1.2x

P/S Ratio

-13.5x

P/E Ratio

Is GRDN overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
GRDN income statement (TTM)
Revenue	US$1.23b
Cost of Revenue	US$984.04m
Gross Profit	US$244.37m
Other Expenses	US$354.42m
Earnings	-US$110.05m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-1.74
Gross Margin	19.89%
Net Profit Margin	-8.96%
Debt/Equity Ratio	0%

How did GRDN perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/04/16 17:17
End of Day Share Price	2025/04/16 00:00
Earnings	2024/12/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Guardian Pharmacy Services, Inc. is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Kam Wai Kwok	CGS International
John Ransom	Raymond James & Associates
Scott Fidel	Stephens, Inc.